Open Access
CC BY-NC-ND 4.0 · Endosc Int Open 2024; 12(11): E1360-E1365
DOI: 10.1055/a-2411-9979
Original article

Intraoperative bleeding model for swine gastric endoscopic submucosal dissection via heparinization

1   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
,
Motoki Sasaki
1   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
,
Moe Sato
2   Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
3   Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
,
Daisuke Minezaki
1   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
,
Kohei Morioka
1   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
3   Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
,
Anna Tojo
2   Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
3   Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
,
Hinako Sakurai
2   Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
3   Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
,
Kentaro Iwata
1   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
3   Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
,
Kurato Miyazaki
1   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
3   Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
,
Yoko Kubosawa
1   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
3   Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
,
Mari Mizutani
1   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
3   Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
,
1   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
,
Yusaku Takatori
1   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
,
Shintaro Kawasaki
2   Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
,
1   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
,
Atsushi Nakayama
1   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
,
Tomohisa Sujino
2   Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
,
Kaoru Takabayashi
2   Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
,
Naohisa Yahagi
1   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
,
4   Department of Next Generation Endoscopic Intervention (Project ENGINE), Osaka University Graduate School of Medicine, Osaka, Japan (Ringgold ID: RIN38637)
,
2   Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
› Institutsangaben
Preview

Abstract

Background and study aims: Live swine have a high degree of coagulation and aggregation and using them for training about how to manage intraoperative bleeding during endoscopic submucosal dissection (ESD) is unsatisfactory. This study aimed to identify the appropriate heparin dose in an intraoperative bleeding model and validate its applicability.

Methods: First, we explored the dose of heparin required for a swine bleeding model in which the activated clotting time reached and maintained the upper limit of measurement (1500 s) after 10 minutes. Second, we compared intraoperative bleeding and hematoma frequency during ESD for 2-cm lesions between the heparinized bleeding model and control groups. Intraoperative bleeding was classified according to the Forrest classification.

Results: The combination of a bolus (300 U/kg), continuous infusion (300 U/kg/h), and a bolus dose (150 U/kg) of heparin 10 minutes after the first infusion was identified as the dose for the bleeding model. Five ESDs were performed in each heparinized bleeding model and the control group. The median number of intraoperative bleeds was significantly higher in the heparinized model than in the control group (5 interquartile range [IQR] 4–7 vs. 3 [IQR 0–4, P = 0.028). All of the intraoperative bleeding events oozing (Forrest Ib) rather than spurting (Forrest Ia). The median number of hematomas was significantly higher in the heparinized model group than in the control group (3 [IQR 1–4] vs. 0 [IQR 0–1], P = 0.023).

Conclusions: High doses of heparin significantly increased intraoperative bleeding and hematoma during swine ESD.

Supplementary Material



Publikationsverlauf

Eingereicht: 07. März 2024

Angenommen nach Revision: 09. September 2024

Accepted Manuscript online:
18. Oktober 2024

Artikel online veröffentlicht:
28. November 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany